Unique Tetratricopeptide Repeat Domain 23 (TTC23L) as A Potential Drug Target Or Biomarker

Target Name: TTC23L

NCBI ID: G153657

TTC23L

Unique Tetratricopeptide Repeat Domain 23 (TTC23L) as A Potential Drug Target Or Biomarker

Tetratricopeptide repeat domain 23 (TTC23L) is a protein that is expressed in various tissues and cells in the human body. It is a member of the superfamily of repetitive protein domains, which are characterized by a repeated sequence of amino acids that is conserved across different organisms. TTC23L is unique because it is a four-peptide repeat domain, which is not typically found in proteins that are this long.

The TTC23L protein is also unique due to its role in the development and progression of various diseases. For example, it has been shown to be involved in the development of cancer, and it has also been linked to the development of neurodegenerative diseases. This has led to TTC23L being considered as a potential drug target or biomarker.

One of the key features of TTC23L is its ability to interact with various signaling pathways. It has been shown to interact with multiple signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. This has led to its potential as a drug target, as drugs that target these pathways have been shown to be effective in treating various diseases.

Another unique feature of TTC23L is its structure. It has a unique four-peptide repeat domain, which is made up of four amino acids that are highly conserved across different organisms. This has led to its structure being well- conserved, which has implications for its function in the cell.

TTC23L has also been shown to play a role in regulating cellular processes. For example, it has been shown to be involved in the regulation of cell adhesion, which is important for various cellular processes, such as cell signaling and tissue formation. This has led to its potential as a drug target or biomarker in diseases that are characterized by disrupted cell adhesion.

In conclusion, TTC23L is a unique protein that has been shown to be involved in the development and progression of various diseases. Its ability to interact with multiple signaling pathways and its unique structure have led to its potential as a drug target or biomarker. Further research is needed to fully understand its role in the cell and its potential as a therapeutic agent.

Protein Name: Tetratricopeptide Repeat Domain 23 Like

The "TTC23L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TTC23L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets